Mike Karim, Oxford Endovascular - Spotlight Interview | LSI Europe ‘23

Speakers

Mike Karim

Mike Karim

CEO, Oxford Endovascular
Read Biography
Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms.

LSI USA '24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders in Dana Point.

JOIN US TODAY

Share this video

Companies We Work With